academic article

• Mitochondrial haplogroups and cognitive progression in Parkinson's disease..  Brain : a journal of neurology.  146:42-49. 2023
• Joint Modeling Study Identifies Blood-Based Transcripts Link to Cognitive Decline in Parkinson's Disease..  Movement disorders : official journal of the Movement Disorder Society.  37:2386-2395. 2022
• Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI..  NPJ Parkinson's disease.  7:-. 2021
• Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease..  Nature genetics.  53:787-793. 2021
• GBA.  Neurology.  95:e685-e696. 2020
• Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease..  Nature neuroscience.  22:144-147. 2019
• Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease..  Nature neuroscience.  21:1482-1492. 2018
• Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts..  The Lancet. Neurology.  16:620-629. 2017
• Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's..  Annals of neurology.  80:674-685. 2016
• Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease..  Brain : a journal of neurology.  138:2659-71. 2015